Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
12 December 2020 |
Main ID: |
NCT02610608 |
Date of registration:
|
18/11/2015 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Medical Assistance for the Procreation and Risk of Thrombosis.
AMPERT |
Scientific title:
|
Assistance Médicale à la Procréation et Risque Thrombotique |
Date of first enrolment:
|
February 2, 2016 |
Target sample size:
|
129 |
Recruitment status: |
Terminated |
URL:
|
https://clinicaltrials.gov/show/NCT02610608 |
Study type:
|
Observational |
Study design:
|
|
Phase:
|
|
|
Countries of recruitment
|
France
| | | | | | | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- All women undergoing ovarian stimulation in order to receive in vitro fertilization
Exclusion Criteria:
- Age<18 years
- Women refusing to particpate in the study
- No health coverage
- Women under guardianship
- Women receiving therapeutic doses of anticoagulation
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Female
|
Health Condition(s) or Problem(s) studied
|
Ovarian Hyperstimulation Syndrome
|
Cardiovascular Diseases
|
Embolism and Thrombosis
|
Intervention(s)
|
Other: ovarian stimulation
|
Primary Outcome(s)
|
Evaluation of professional clinical practice for ovarian stimulation care
[Time Frame: Until 12 months followin ovarian stimulation]
|
Secondary Outcome(s)
|
Arterial and/or venous thrombosis
[Time Frame: until 12 months following ovarian stimulation]
|
Risk factors for thrombosis
[Time Frame: until 12 months following ovarian stimulation]
|
Secondary ID(s)
|
AMPERT (RB13.160)
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|